News | May 29, 2015

Public-Private Partnership Restarting Mo-99 Production in U.S.

Cooperative R&D agreement will develop scalable standalone system for domestic production

May 29, 2015 — National Security Technologies LLC (NSTec) and Henderson, Nevada-based Global Medical Isotope Systems (GMIS) announced a public-private partnership agreement for research and development of an essential radioactive isotope used in millions of medical diagnostic imaging procedures annually.

Known primarily as the management and operations contractor for the Nevada National Security Site (NNSS), NSTec is leveraging its traditional national security role with the signing of its first cooperative research and development agreement (CRADA). The agreement describes NSTec's technical integration, modeling, materials and design support to GMIS's mission in the development and deployment of a ground-breaking approach to the production of the radioactive isotope molybdenum-99 (Mo-99).

By introducing a safe, decentralized, on-demand production system using non-enriched uranium, the two companies are answering a critical supply need of the medical imaging community. The United States terminated its domestic Mo-99 production in the 1990s, but continues to import the isotope from Canada and Europe. In addition, U.S. and global demand for Mo-99 has grown substantially in recent years, making easy and timely access to supplies of the isotope more important than ever.

The imaging isotope Technetium-99m (Tc-99m) is a decay by-product of Mo-99, and has a half-life of only about 6 hours. This unique physical characteristic makes Tc-99m the most widely used medical diagnostic isotope in nuclear medicine. Its short half-life allows it to be used in body-scanning procedures that collect data rapidly, but keeps total patient radiation exposure low — but it also makes keeping an inventory next to impossible. 

Presently, there are about 40 million imaging and diagnostic procedures performed worldwide per year, of which 80-85 percent use Tc-99m. Of those 40 million, more than 20 million are performed in North America, about 1.5 million in Canada, and approximately 15,000 in southern Nevada.

GMIS is currently developing a scalable standalone system to produce the isotope, allowing for custom deployments to other areas of the country.

The five-year CRADA calls for NSTec to provide technical integration, modeling, materials, and design support to GMIS's mission.  

NSTec also brings to the CRADA a staff of nuclear and health physicists, skilled physics and electronics technicians, a variety of radiological materials, and an extensive inventory of radiation detection equipment.

For more information: www.nstec.com

Related Content

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 26, 2018 | Dave Fornell
February 8, 2018 — The U.S.
ARTMS Products Inc. and GE Healthcare Team Up to Expand Cyclotron-Produced Radioisotopes
News | Radiopharmaceuticals and Tracers | August 30, 2017
ARTMS Products Inc. signed a strategic partnership with GE Healthcare around ARTMS’ proprietary QUANTM99 Irradiation...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017
Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the signing of a...
Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields
News | Radiopharmaceuticals and Tracers | April 28, 2017
Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the development of a new...
University of Missouri Research Reactor Files to Start U.S. Production of Medical Isotopes
News | Radiopharmaceuticals and Tracers | April 13, 2017
The University of Missouri Research Reactor (MURR) and its partners Nordion and General Atomics (GA), announced in...
IBA Molecular and Mallinckrodt Nuclear Medicine Merge to Become Curium
News | Radiopharmaceuticals and Tracers | April 11, 2017
April 11, 2017 — IBA Molecular announced that it has merged with previous acquisition Mallinckrodt...
GE Healthcare, HealthTrust, supply agreement, nuclear imaging, radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | April 05, 2017
April 5, 2017 — GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered
Nuclear cardiology, nuclear imaging, radiotracer production, automated radiosynthesis module, myocardial perfusion imaging
Feature | Radiopharmaceuticals and Tracers | March 01, 2017 | Anamika Kumari
Huge portions of the globally produced radiotracers find their origin within geographically centralized, commercial r
News | Radiopharmaceuticals and Tracers | January 17, 2017
NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of Energy’s National...
SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | December 28, 2016
December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States Pharmac
Overlay Init